RA disease duration was 10 (interquartile range 3–20) years, 44% of the patients were receiving corticosteroid treatment, 32% were receiving anti-tumor necrosis factor (TNF) therapy, and 65% were seropositive for rheumatoid factor (Table 1). Here, TNF is linked to rheumatoid arthritis.